SK177897A3 - Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a - Google Patents
Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a Download PDFInfo
- Publication number
- SK177897A3 SK177897A3 SK1778-97A SK177897A SK177897A3 SK 177897 A3 SK177897 A3 SK 177897A3 SK 177897 A SK177897 A SK 177897A SK 177897 A3 SK177897 A3 SK 177897A3
- Authority
- SK
- Slovakia
- Prior art keywords
- carbon atoms
- group
- alkyl
- aryl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH191495 | 1995-06-29 | ||
| PCT/EP1996/002785 WO1997001569A1 (en) | 1995-06-29 | 1996-06-26 | Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK177897A3 true SK177897A3 (en) | 1998-08-05 |
Family
ID=4221546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1778-97A SK177897A3 (en) | 1995-06-29 | 1996-06-26 | Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0836610A1 (zh) |
| JP (1) | JPH11508548A (zh) |
| KR (1) | KR19990028543A (zh) |
| CN (1) | CN1196731A (zh) |
| AU (1) | AU707474B2 (zh) |
| BR (1) | BR9609285A (zh) |
| CA (1) | CA2224346A1 (zh) |
| CZ (1) | CZ419797A3 (zh) |
| EA (1) | EA001356B1 (zh) |
| HU (1) | HUP9801805A3 (zh) |
| IL (1) | IL118740A0 (zh) |
| MX (1) | MX9800218A (zh) |
| NO (1) | NO976065L (zh) |
| NZ (1) | NZ311686A (zh) |
| PL (1) | PL324258A1 (zh) |
| SI (1) | SI9620099A (zh) |
| SK (1) | SK177897A3 (zh) |
| TR (1) | TR199701728T1 (zh) |
| WO (1) | WO1997001569A1 (zh) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002036587A2 (en) | 2000-11-01 | 2002-05-10 | Cor Therapeutics, Inc. | Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
| EP1577289A1 (en) * | 2004-03-18 | 2005-09-21 | Revotar Biopharmaceuticals AG | Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders |
| AU2006284578B2 (en) | 2005-09-02 | 2011-01-27 | Glycomimetics, Inc. | Heterobifunctional pan-selectin inhibitors |
| EP1764096A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel phloroglucinol derivatives having selectin ligand activity |
| EP1764095A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel nitrocatechol derivatives having selectin ligand activity |
| EP1764093A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel aromatic compounds and their use in medical applications |
| JP5298020B2 (ja) * | 2006-10-12 | 2013-09-25 | グリコミメティクス， インコーポレイテッド | ヘキソースおよびｎ−アセチルヘキソサミンの糖模倣体置換 |
| JP5511390B2 (ja) * | 2007-02-09 | 2014-06-04 | グリコミメティクス， インコーポレイテッド | ヘキソースおよびｎ−アセチルヘキソサミンの置換体を有する糖模倣体の使用方法 |
| WO2009126556A1 (en) | 2008-04-08 | 2009-10-15 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
| WO2012037034A1 (en) | 2010-09-14 | 2012-03-22 | Glycomimetics, Inc. | E-selectin antagonists |
| JP2015500887A (ja) | 2011-12-22 | 2015-01-08 | グリコミメティクス， インコーポレイテッド | Ｅ−セレクチンアンタゴニスト化合物、組成物および使用方法 |
| AU2013355238B2 (en) | 2012-12-07 | 2017-12-14 | Glycomimetics, Inc. | Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells |
| SI3227310T1 (sl) | 2014-12-03 | 2019-11-29 | Glycomimetics Inc | Heterobifunkcionalni inhibitorji e-selektinov in receptorjev kemokina CXCR4 |
| CA3009836A1 (en) | 2016-01-22 | 2017-07-27 | Glycomimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
| US11291678B2 (en) | 2016-03-02 | 2022-04-05 | Glycomimetics, Inc | Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin |
| WO2018031445A1 (en) | 2016-08-08 | 2018-02-15 | Glycomimetics, Inc. | Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4 |
| JP7069136B2 (ja) | 2016-10-07 | 2022-05-17 | グリコミメティクス， インコーポレイテッド | 極めて強力な多量体ｅ－セレクチンアンタゴニスト |
| EP3596096A1 (en) | 2017-03-15 | 2020-01-22 | GlycoMimetics, Inc. | Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists |
| JP7275131B2 (ja) | 2017-11-30 | 2023-05-17 | グリコミメティクス， インコーポレイテッド | 骨髄浸潤リンパ球を動員する方法、およびその使用 |
| CN111566117A (zh) | 2017-12-29 | 2020-08-21 | 糖模拟物有限公司 | E-选择蛋白和半乳凝素-3的异双功能抑制剂 |
| JP7455064B2 (ja) | 2018-03-05 | 2024-03-25 | グリコミメティクス， インコーポレイテッド | 急性骨髄性白血病および関連状態を処置する方法 |
| WO2020139962A1 (en) | 2018-12-27 | 2020-07-02 | Glycomimetics, Inc. | Heterobifunctional inhibitors of e-selectin and galectin-3 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5326752A (en) * | 1991-11-27 | 1994-07-05 | Glycomed Incorporated | Substituted lactose and lactosamine derivatives as cell adhesion inhibitors |
| WO1993023031A1 (en) * | 1992-05-08 | 1993-11-25 | The Biomembrane Institute | Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response |
| CA2100412A1 (en) * | 1992-07-15 | 1994-01-16 | Yutaka Yamada | Glycolipid derivatives |
-
1996
- 1996-06-26 NZ NZ311686A patent/NZ311686A/xx unknown
- 1996-06-26 IL IL11874096A patent/IL118740A0/xx unknown
- 1996-06-26 SK SK1778-97A patent/SK177897A3/sk unknown
- 1996-06-26 BR BR9609285A patent/BR9609285A/pt not_active Application Discontinuation
- 1996-06-26 EP EP96922034A patent/EP0836610A1/en not_active Ceased
- 1996-06-26 JP JP9504171A patent/JPH11508548A/ja active Pending
- 1996-06-26 CZ CZ974197A patent/CZ419797A3/cs unknown
- 1996-06-26 CA CA002224346A patent/CA2224346A1/en not_active Abandoned
- 1996-06-26 EA EA199800103A patent/EA001356B1/ru not_active IP Right Cessation
- 1996-06-26 PL PL96324258A patent/PL324258A1/xx unknown
- 1996-06-26 SI SI9620099A patent/SI9620099A/sl unknown
- 1996-06-26 KR KR1019970709861A patent/KR19990028543A/ko not_active Application Discontinuation
- 1996-06-26 AU AU63053/96A patent/AU707474B2/en not_active Ceased
- 1996-06-26 HU HU9801805A patent/HUP9801805A3/hu unknown
- 1996-06-26 CN CN96196452A patent/CN1196731A/zh active Pending
- 1996-06-26 WO PCT/EP1996/002785 patent/WO1997001569A1/en not_active Application Discontinuation
- 1996-06-26 TR TR97/01728T patent/TR199701728T1/xx unknown
-
1997
- 1997-12-23 NO NO976065A patent/NO976065L/no not_active Application Discontinuation
-
1998
- 1998-01-07 MX MX9800218A patent/MX9800218A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6305396A (en) | 1997-01-30 |
| NZ311686A (en) | 2000-01-28 |
| KR19990028543A (ko) | 1999-04-15 |
| NO976065D0 (no) | 1997-12-23 |
| EA001356B1 (ru) | 2001-02-26 |
| EA199800103A1 (ru) | 1998-08-27 |
| BR9609285A (pt) | 1999-05-11 |
| CN1196731A (zh) | 1998-10-21 |
| MX9800218A (es) | 1998-07-31 |
| PL324258A1 (en) | 1998-05-11 |
| JPH11508548A (ja) | 1999-07-27 |
| TR199701728T1 (xx) | 1998-03-21 |
| NO976065L (no) | 1998-02-17 |
| IL118740A0 (en) | 1996-10-16 |
| HUP9801805A3 (en) | 2002-01-28 |
| HUP9801805A2 (hu) | 1998-12-28 |
| EP0836610A1 (en) | 1998-04-22 |
| CA2224346A1 (en) | 1997-01-16 |
| WO1997001569A1 (en) | 1997-01-16 |
| AU707474B2 (en) | 1999-07-08 |
| SI9620099A (sl) | 1998-08-31 |
| CZ419797A3 (cs) | 1998-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK177897A3 (en) | Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a | |
| US7893279B2 (en) | Cyclohexanecarboxylic acid compound | |
| SK15699A3 (en) | Modified oligosaccharides, process for their preparation and pharmaceutical composition containing them | |
| IL105810A (en) | History of erythromycin and the pharmaceutical preparations containing them | |
| JP3004297B2 (ja) | リゾスフィンゴ脂質誘導体 | |
| JPWO2002036602A1 (ja) | 新規ピラゾール誘導体及びそれらを含有する糖尿病治療薬 | |
| CA2661166A1 (en) | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
| CS205027B2 (en) | Method of producing glucosamine derivatives | |
| KR910003641B1 (ko) | 무라밀 펩타이드의 제조방법 | |
| CN111936489A (zh) | 新的白纹黄单胞菌毒素衍生物、其用途及合成 | |
| US7037899B2 (en) | Derivatives of monosaccharides as cell adhesion inhibitors | |
| EP1284984B1 (fr) | Derives de l'uridine comme antibiotiques | |
| WO2021233133A1 (zh) | 用作ret激酶抑制剂的化合物及其应用 | |
| JP2003512473A (ja) | ハイグロマイシン誘導体 | |
| CZ410498A3 (cs) | Polyolové sukcináty a jejich farmaceutické formulace | |
| JPS6310717B2 (zh) | ||
| WO2021113922A1 (en) | Improved method for preparing n-(benzenesulfonyl)-l-prolyl- l-o-(1-pyrrolidinylcarbonyl)tyrosine | |
| JP2000212191A (ja) | リン酸誘導体 | |
| JPS62234092A (ja) | 新規グルコ−ス誘導体 | |
| JPS615089A (ja) | 新規アミノグリコシド誘導体 |